Supplemental material
Emerging Microbes & Infections
Volume 8, 2019 - Issue 1
Original Articles
Cisplatin protects mice from challenge of Cryptococcus neoformans by targeting the Prp8 intein
Zhong Lia New York State Department of Health, Wadsworth Center, Albany, NY, USA
https://orcid.org/0000-0002-1039-7000View further author information
https://orcid.org/0000-0002-1039-7000View further author information, , , , , , , , & Hongmin Lia New York State Department of Health, Wadsworth Center, Albany, NY, USA;d Department of Biomedical Sciences, School of Public Health, University at Albany, Albany, NY, USACorrespondence[email protected]
https://orcid.org/0000-0002-8684-5308View further author information
https://orcid.org/0000-0002-8684-5308View further author information show allRelated Research Data
Cisplatin in cancer therapy: molecular mechanisms of action
Source:
Elsevier BV
The PRP8 inteins in Cryptococcus are a source of phylogenetic and epidemiological information
Source:
Elsevier BV
Crystal structure of a mini-intein reveals a conserved catalytic module involved in side chain cyclization of asparagine during protein splicing.
Source:
Elsevier BV
Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy.
Source:
Ovid Technologies (Wolters Kluwer Health)
Enigmatic Distribution, Evolution, and Function of Inteins
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients.
Source:
Public Library of Science (PLoS)
Cisplatin Inhibits Protein Splicing, Suggesting Inteins as Therapeutic Targets in Mycobacteria
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections
Source:
Springer Science and Business Media LLC
Practice Guidelines for the Management of Cryptococcal Disease
Source:
Oxford University Press (OUP)
Cryptococcus neoformans Infection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome
Source:
Centers for Disease Control and Prevention
Overview of invasive fungal infections.
Source:
Humana Press
The Challenge Continues
Source:
Springer Science and Business Media LLC
Prp8 intein in fungal pathogens: target for potential antifungal drugs
Source:
Federation of European Biochemical Societies. Published by Elsevier B.V.
Crystallographic and mutational studies of Mycobacterium tuberculosis recA mini-inteins suggest a pivotal role for a highly conserved aspartate residue.
Source:
Elsevier BV
Evaluation of Endpoints for Antifungal Susceptibility Determinations with LY303366
Source:
American Society for Microbiology
A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections
Source:
Springer Science and Business Media LLC
Cisplatin protects mice from challenge of Cryptococcus neoformans by targeting the Prp8 intein
Source:
Taylor & Francis
Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure
Source:
Centers for Disease Control and Prevention (CDC)
Split-luciferase complementary assay: applications, recent developments, and future perspectives
Source:
Springer Science and Business Media LLC
The Challenge Continues
Source:
Springer Science and Business Media LLC
Prp8 protein: At the heart of the spliceosome
Source:
Cold Spring Harbor Laboratory
Structural basis of pre-mRNA splicing
Source:
American Association for the Advancement of Science (AAAS)
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
Source:
Public Library of Science (PLoS)
Clinical Issues Regarding Relapsing Aspergillosis and the Efficacy of Secondary Antifungal Prophylaxis in Patients with Hematological Malignancies
Source:
Oxford University Press (OUP)
Cisplatin protects mice from challenge of Cryptococcus neoformans by targeting the Prp8 intein
Source:
Taylor & Francis
Monitoring Protein–Protein Interactions Using Split Synthetic Renilla Luciferase Protein-Fragment-Assisted Complementation
Source:
American Chemical Society (ACS)
Inteins as targets for potential antimycobacterial drugs.
Source:
IMR Press
The Challenge Continues
Source:
Springer Science and Business Media LLC
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
Source:
American Society for Microbiology
Sequence requirements for splicing by the Cne PRP8 intein.
Source:
Federation of European Biochemical Societies. Published by Elsevier B.V.
Protein splicing inhibitors as a new class of antimycobacterial agents
Source:
Clarivate Analytics (US)
A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections
Source:
Springer Science and Business Media LLC
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Source:
International Union of Crystallography (IUCr)
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.
Source:
Elsevier BV
Evolution and Application of Inteins in Candida species: A Review.
Source:
Frontiers Media SA
Global burden of chronic pulmonary aspergillosis complicating sarcoidosis
Source:
European Respiratory Society (ERS)
Fungal Infections
Source:
Elsevier BV
Linking provided by
